← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Courage Therapeutics, Inc.
Newton, MA
$2,164,996
Total funding
3
Grants
Funding over time
peak $862.7K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,164,996 · 3
By mechanism
R42$1,669,553 · 1
R41$495,443 · 2
Investigators at Courage Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of Novel Melanocortin-4 Receptor Peptide Agonists for the Treatment ofMC4R Haploinsufficiency$862,674
R42 · FY2023 · DK
Development of Novel Melanocortin-4 Receptor Peptide Agonists for the Treatment ofMC4R Haploinsufficiency$806,879
R42 · FY2022 · DK
Development of Melanocortin-3 Receptor Peptide Agonists for the Treatment of Anorexia Nervosa$250,538
R41 · FY2021 · MH
Development of Melanocortin-3 Receptor Peptide Antagonists for the Treatment of Obesity and Maintenance of Weight Loss$244,905
R41 · FY2020 · DK